Aberrant Promoter Hypomethylation of Sortilin 1: A Moyamoya Disease Biomarker

BACKGROUND AND PURPOSE: The pathogenesis of moyamoya disease (MMD) remains poorly understood, and no reliable molecular biomarkers for MMD have been identified to date. The present study aimed to identify epigenetic biomarkers for use in the diagnosis of MMD. METHODS: We performed integrated analyse...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Stroke
Hauptverfasser: Sung, Hye Youn, Lee, Ji Yeoun, Park, Ae Kyung, Moon, Youn Joo, Jo, Inho, Park, Eun-Mi, Wang, Kyu-Chang, Phi, Ji Hoon, Ahn, Jung-Hyuck, Kim, Seung-Ki
Format: Artigo
Sprache:Inglês
Veröffentlicht: Korean Stroke Society 2018
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6186926/
https://ncbi.nlm.nih.gov/pubmed/30309230
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5853/jos.2018.00962
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge